Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2004 4
2005 6
2006 5
2007 6
2008 4
2009 6
2010 8
2011 7
2012 7
2013 6
2014 6
2015 13
2016 6
2017 11
2018 7
2019 8
2020 10
2021 8
2022 9
2023 12
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

139 results

Results by year

Filters applied: . Clear all
Page 1
Emerging Direct Targeting β-Catenin Agents.
Nalli M, Masci D, Urbani A, La Regina G, Silvestri R. Nalli M, et al. Among authors: silvestri r. Molecules. 2022 Nov 10;27(22):7735. doi: 10.3390/molecules27227735. Molecules. 2022. PMID: 36431838 Free PMC article. Review.
Emerging Therapeutic Agents for Colorectal Cancer.
Nalli M, Puxeddu M, La Regina G, Gianni S, Silvestri R. Nalli M, et al. Among authors: silvestri r. Molecules. 2021 Dec 9;26(24):7463. doi: 10.3390/molecules26247463. Molecules. 2021. PMID: 34946546 Free PMC article. Review.
Toll-Like Receptor 4-Dependent Platelet-Related Thrombosis in SARS-CoV-2 Infection.
Carnevale R, Cammisotto V, Bartimoccia S, Nocella C, Castellani V, Bufano M, Loffredo L, Sciarretta S, Frati G, Coluccia A, Silvestri R, Ceccarelli G, Oliva A, Venditti M, Pugliese F, Maria Mastroianni C, Turriziani O, Leopizzi M, D'Amati G, Pignatelli P, Violi F. Carnevale R, et al. Among authors: silvestri r. Circ Res. 2023 Feb 3;132(3):290-305. doi: 10.1161/CIRCRESAHA.122.321541. Epub 2023 Jan 13. Circ Res. 2023. PMID: 36636919 Free article.
Modulating undruggable targets to overcome cancer therapy resistance.
Passirani C, Vessières A, La Regina G, Link W, Silvestri R. Passirani C, et al. Among authors: silvestri r. Drug Resist Updat. 2022 Jan;60:100788. doi: 10.1016/j.drup.2021.100788. Epub 2021 Dec 3. Drug Resist Updat. 2022. PMID: 35168144 Review.
Towards modern anticancer agents that interact with tubulin.
La Regina G, Coluccia A, Naccarato V, Silvestri R. La Regina G, et al. Among authors: silvestri r. Eur J Pharm Sci. 2019 Apr 1;131:58-68. doi: 10.1016/j.ejps.2019.01.028. Epub 2019 Jan 25. Eur J Pharm Sci. 2019. PMID: 30690185 Review.
N-Pyrrylarylsulfones with High Therapeutic Potential.
Famiglini V, Castellano S, Silvestri R. Famiglini V, et al. Among authors: silvestri r. Molecules. 2017 Mar 9;22(3):434. doi: 10.3390/molecules22030434. Molecules. 2017. PMID: 28282943 Free PMC article. Review.
4-(3-Phenyl-4-(3,4,5-trimethoxybenzoyl)-1H-pyrrol-1-yl)benzenesulfonamide, a Novel Carbonic Anhydrase and Wnt/β-Catenin Signaling Pathway Dual-Targeting Inhibitor with Potent Activity against Multidrug Resistant Cancer Cells.
Masci D, Puxeddu M, Di Magno L, D'Ambrosio M, Parisi A, Nalli M, Bai R, Coluccia A, Sciò P, Orlando V, D'Angelo S, Biagioni S, Urbani A, Hamel E, Nocentini A, Filiberti S, Turati M, Ronca R, Kopecka J, Riganti C, Fionda C, Bordone R, Della Rocca G, Canettieri G, Supuran CT, Silvestri R, La Regina G. Masci D, et al. Among authors: silvestri r. J Med Chem. 2023 Nov 9;66(21):14824-14842. doi: 10.1021/acs.jmedchem.3c01424. Epub 2023 Oct 30. J Med Chem. 2023. PMID: 37902628 Free PMC article.
139 results